These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1948542)
1. [Porcine factor VIII]. De Juan MJ; Montoro JB; Tusell JM Sangre (Barc); 1991 Jun; 36(3):217-20. PubMed ID: 1948542 [No Abstract] [Full Text] [Related]
2. Porcine factor VIII: preparation and use in treatment of inhibitor patients. Kernoff PB Prog Clin Biol Res; 1984; 150():207-24. PubMed ID: 6431429 [No Abstract] [Full Text] [Related]
3. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors. Bell BA Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549 [No Abstract] [Full Text] [Related]
4. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance. Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297 [TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance using porcine factor VIII. Hay CR; Laurian Y Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473 [No Abstract] [Full Text] [Related]
6. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192 [TBL] [Abstract][Full Text] [Related]
7. Porcine factor VIIIC in the management of patients with factor VIII inhibitors. Hay CR; Bolton-Maggs P Transfus Med Rev; 1991 Oct; 5(4):293-9. PubMed ID: 1802286 [No Abstract] [Full Text] [Related]
8. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia]. Windyga J; Rzymkiewicz L; Lopaciuk S Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440 [TBL] [Abstract][Full Text] [Related]
9. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects. Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768 [No Abstract] [Full Text] [Related]
10. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and immune tolerance coagulation Factors VIII and IX. Rup B Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504 [TBL] [Abstract][Full Text] [Related]
12. Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group. Abildgaard CF Semin Hematol; 1991 Apr; 28(2 Suppl 1):44. PubMed ID: 1908127 [No Abstract] [Full Text] [Related]
13. Treatment of factor VIII inhibitors. Kasper CK Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380 [No Abstract] [Full Text] [Related]
14. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Reipert BM; van Helden PM; Schwarz HP; Hausl C Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196 [TBL] [Abstract][Full Text] [Related]
17. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII. Verroust F; Allain JP Thromb Haemost; 1982 Oct; 48(2):238. PubMed ID: 6817447 [No Abstract] [Full Text] [Related]
18. Does peroral administration of factor VIII induce oral tolerance in patients with acquired haemophilia A? Lindgren A; Wadenvik H; Tarkowski A; Tengborn L Thromb Haemost; 2000 Apr; 83(4):632-3. PubMed ID: 10780332 [No Abstract] [Full Text] [Related]